Short Interest in Indivior PLC (NASDAQ:INDV) Increases By 15.8%

Indivior PLC (NASDAQ:INDV) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 201,800 shares, a growth of 15.8% from the March 31st total of 174,300 shares. Based on an average daily trading volume, of 129,300 shares, the days-to-cover ratio is presently 1.6 days. Approximately 0.2% of the shares of the stock are sold short.

Indivior Trading Up 2.0 %

NASDAQ:INDV traded up $0.35 during midday trading on Monday, hitting $17.93. 165,976 shares of the company traded hands, compared to its average volume of 122,442. The firm has a market capitalization of $2.47 billion, a P/E ratio of 1,758.00 and a beta of 0.46. The firm’s fifty day moving average is $20.49 and its 200-day moving average is $18.29. Indivior has a 12-month low of $14.38 and a 12-month high of $26.50. The company has a current ratio of 0.92, a quick ratio of 0.74 and a debt-to-equity ratio of 23.50.

Indivior (NASDAQ:INDV) last released its earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.15. Indivior had a net margin of 0.44% and a return on equity of 842.72%. The firm had revenue of $293.00 million during the quarter, compared to analyst estimates of $260.00 million. On average, sell-side analysts predict that Indivior will post 2.03 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of INDV. Chilton Investment Co. Inc. purchased a new stake in Indivior in the fourth quarter worth $263,000. ADAR1 Capital Management LLC purchased a new position in Indivior in the 4th quarter worth about $368,000. Cannon Global Investment Management LLC purchased a new position in Indivior in the 1st quarter worth about $563,000. Campbell & CO Investment Adviser LLC lifted its holdings in Indivior by 2.8% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 37,948 shares of the company’s stock valued at $573,000 after buying an additional 1,037 shares in the last quarter. Finally, Hsbc Holdings PLC bought a new position in Indivior in the 4th quarter worth about $649,000. Institutional investors own 60.33% of the company’s stock.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on Indivior in a research note on Wednesday, April 3rd. They set a “buy” rating and a $37.00 price objective on the stock.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.